Skip to main content
. 2020 Sep 9;31(11):1047–1060. doi: 10.1111/clr.13651

TABLE 2.

Radiographic and clinical parameters (mean (SD) at baseline, 6 and 12 months of the 24 peri‐implant defects

Parameter BO EB Between‐group comparison a
BL (mm)
Baseline 5.3 (1.2) 4.9 (1.1) T = 0.885, p = .386
6 months 3.3 (1.3) 2.5 (1.1) T = 1.524, p = .142
12 months 3.1 (1.3) 2.1 (1.3) T = 1.881, p = .073
Within‐group comparison b F = 76.890, p < .001 F = 46.724, p < .001
IDD (mm)
Baseline 4.9 (0.9) 5.9 (1.8) T = −1.763, p = .094
6 months 2.6 (0.6) 3.1 (1.8) T = −0.979, p = .345
12 months 2.4 (0.6) 2.9 (1.3) T = −1.385, p = .183
Within‐group comparison b F = 71.544, p < .001 F = 49.796, p < .001
SC (mm)
Baseline 0.4 (1.2) −0.9 (1.6) T = 2.405, p = .025
6 months 0.7 (1.5) −0.6 (1.8) T = 1.843, p = .080
12 months 0.7 (1.6) −0.6 (1.6) T = 2.359, p = .028
Within‐group comparison b F = 1.646, p = .218 F = 0.985, p = .389
PPD (mm)
Baseline 7.0 (1.8) 7.1 (1.2) T = −0.221, p = .827
6 months 3.5 (1.0) 3.4 (0.6) T = 0.526, p = .604
12 months 3.4 (0.6) 3.4 (0.5) T = 0.115, p = .910
Within‐group comparison b F = 42.449, p < .001 F = 88.502, p < .001
BoP (%)
Baseline 100 (0.0) 100 (0.0) T = 1.359, p = .188
6 months 47.7 (32.5) 32.7 (21.4) T = −0.437, p = .670
12 months 45.5 (33.2) 50 (10.2)
Within‐group comparison b F = 20.331, p < .001 F = 93.638, p < .001
SoP (%)
Baseline 79.5 (40.0) 86.5 (33.3) T = −0.468, p = .645
6 months 4.6 (15.1) 0.0 (0.0) T = 1.000, p = .341
12 months 0.0 (0.0) 1.9 (6.9) T = −0.917, p = .369
Within‐group comparison b F = 35.552, p < .001 F = 84.598, p < .001
Plaque (%)
Baseline 31.7 (13.1) 29.4 (13.0) T = 0.390, p = .701
6 months 15.9 (8.0) 11.5 (6.4) T = 1.461, p = .159
12 months 17.5 (11.5) 14.0 (9.3) T = 0.776, p = .447
Within‐group comparison b F = 12.152, p = .001 F = 12.221, p < .001

Abbreviations: BL, bone level; BO, Bio‐Oss®; BoP, bleeding on probing out of six sites per implant; EB, Endobon®; IDD, intrabony defect depth; PI, full‐mouth plaque index; PPD, probing pocket depth (mean of 6 sites per implant); SC, supracrestal component; SD, standard deviation; SoP, suppuration on probing out of six sites per implant.

a

Independent sample t test.

b

Repeated measures ANOVA.